Un spécialiste a expliqué en détail le danger de la décision d'Anmat sur la vente libre de dix médicaments nécessitant une ordonnance

Argentina’s National Administration of Medicines, Foods and Medical Technology (Anmat) has approved a measure allowing ten previously prescription-only medications to be sold over-the-counter, raising concerns among medical experts about potential health risks. The decision aims to improve public access to these drugs, but specialists warn that the change could lead to increased self-medication and mask underlying conditions requiring professional medical attention. The new regulation means that individuals can purchase these medicines directly from pharmacies without needing a doctor's prescription. However, this shift comes with caveats. According to Dr. Jorge Tartaglione, a specialist who analyzed the issue during a broadcast on LN+, the move does not imply that the drugs are harmless. While they have been evaluated for safety, they still carry the risk of adverse effects, interactions with other treatments, and the possibility of concealing more serious illnesses. Tartaglione emphasized that the removal of the prescription requirement might affect insurance coverage. He noted that some of these medications were previously covered under private health plans and social security programs with discounts. Once classified as over-the-counter, these benefits may disappear even if patients have a valid medical indication. This could place a financial burden on frequent users of the medication, particularly those relying on subsidized healthcare options. The specialist highlighted that while easier access to these drugs is beneficial, it should not encourage unsupervised consumption. He stressed the importance of consulting a healthcare provider before taking any medication, regardless of whether a prescription is required. “Just because a drug is available without a prescription doesn’t mean it’s safe,” he said. “These medications can still cause side effects.” One of the main concerns raised by Tartaglione is the risk of self-diagnosis. Individuals may identify symptoms on their own, buy a drug to alleviate them, and delay seeking professional medical advice. This approach could temporarily suppress symptoms of a more severe condition, leading to delayed diagnosis and treatment. For example, someone experiencing allergy-like symptoms might purchase an antihistamine without realizing that the underlying issue could be something more serious. Another critical point is the potential for drug interactions. Over-the-counter medications can alter the effectiveness of other prescriptions, either enhancing or diminishing their impact. Even herbal remedies and other so-called natural products can produce unintended physiological responses. Tartaglione warned that such interactions could pose significant health risks, especially for individuals managing multiple conditions or taking several medications simultaneously. Dr. Tartaglione reiterated that the ease of purchasing these drugs should not replace professional evaluation. He recommended that anyone experiencing persistent symptoms, unexpected reactions, or needing regular medication consult a physician or a relevant specialist. “Self-medication is very dangerous,” he stated, urging caution and continued reliance on medical expertise. The decision by Anmat reflects a broader effort to enhance public access to essential medications. However, the lack of oversight accompanying this change has sparked debate within the medical community. Experts argue that while improving availability is crucial, it must be paired with robust public education campaigns to ensure responsible usage. They stress that the presence of a drug on store shelves does not eliminate its inherent risks, nor does it negate the need for professional guidance. Health professionals continue to monitor the situation closely, advocating for measures that balance accessibility with patient safety. As the policy takes effect, the focus will remain on ensuring that the public understands the implications of this regulatory shift and the necessity of maintaining medical consultation, even for medications now available without a prescription.